# Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I

> **NCT01004406** · PHASE3 · COMPLETED · sponsor: **VA Office of Research and Development** · enrollment: 59 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DEVICE:** intensive LDL-lowering therapy
- **DRUG:** standard statin monotherapy

## Key facts

- **NCT ID:** NCT01004406
- **Lead sponsor:** VA Office of Research and Development
- **Sponsor class:** FED
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2013-01
- **Final completion:** 2013-03
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2019-07-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01004406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01004406, "Plaque Regression and Progenitor Cell Mobilization With Intensive Lipid Elimination Regimen (PREMIER), Phase I". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01004406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*